Corbus Pharma to Present at 45th Annual Goldman Sachs Healthcare Conference

NORWOOD, Mass., May 30, 2024 - Corbus Pharmaceuticals (NASDAQ: CRBP), commonly referred to as "Corbus" or the "Company," has revealed that its Chief Executive Officer, Yuval Cohen, Ph.D., will deliver a corporate update at the upcoming 45th Annual Goldman Sachs Global Healthcare Conference. This prestigious event is scheduled to take place from June 10-13, 2024, in Miami Beach, Florida.

Conference Details

- Event: 45th Annual Goldman Sachs Global Healthcare Conference
- Participation Format: Presentation and one-on-one investor meetings
- Presentation Date: Wednesday, June 12, 2024
- Presentation Time: 2:40 p.m. ET

Interested parties can access the webcast of the presentation through the provided link.

About Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings, Inc. specializes in precision oncology and boasts a diversified portfolio aimed at combating serious illnesses. The company's innovative scientific approaches leverage well-understood biological pathways to develop new treatments. Corbus' robust pipeline consists of several key candidates:

- CRB-701: A next-generation antibody drug conjugate targeting Nectin-4 on cancer cells. This approach allows the conjugate to deliver a cytotoxic payload directly to the cancerous cells.
- CRB-601: An anti-integrin monoclonal antibody designed to inhibit the activation of TGFβ, a protein expressed on cancer cells, thus potentially altering the tumor microenvironment.
- CRB-913: A highly peripherally restricted CB1 receptor inverse agonist, which is under investigation for the treatment of obesity.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!